Delisting risk
IMRN · NASDAQ · Biotechnology

Immuron (ADR) (IMRN)

Oral bovine-colostrum products for digestive health and travelers’ diarrhea.

$1.18
Pre-market0.00 (0.00%)
At close$1.18(+10.28%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Aug '24Sep '24Feb '25Mar '25Aug '25Feb '26Aug '26Aug '26
Reported−$0.57−$0.15−$0.27−$0.14−$0.31−$0.20$0.00−$0.17
Estimate−$0.01−$0.01−$0.01$0.00$0.00
Surprise−1,922.7%−2,219.5%−2,586.2%

RevenueReportedEstimate

Aug '24Sep '24Feb '25Mar '25Aug '25Feb '26Aug '26Aug '26
Reported$1.7M$1.4M$2.5M$985.8K$2.2M$3.0M$2.7M$2.5M
Estimate$1.7M$2.0M$2.9M$2.7M$2.7M
Surprise+48.3%+7.9%+3.1%0.0%−9.7%

History

DateEstimateReportedSurprise
Aug 2026$0.00−$0.17
Aug 2026$0.00$0.00
Feb 2026−$0.01−$0.20−2,586.2%
Aug 2025−$0.01−$0.31−2,219.5%

The latest year is open to everyone — the 33 quarters behind it read with an account.

Sign in
Mar 2025
Feb 2025
Sep 2024
Aug 2024
Apr 2024
Mar 2024
Aug 2023
Dec 2022
Aug 2022
Aug 2022
Dec 2021
Sep 2021
Dec 2020
Aug 2020
Jun 2020
Dec 2019
Aug 2019
Dec 2018
Jun 2018
Dec 2017
Jun 2017
Dec 2016
Jun 2016
Dec 2015
Jun 2015
Dec 2014
Jun 2014
Dec 2013
Jun 2013
Dec 2012
Jun 2006
Dec 2005
Jun 2003
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Aug 28, 2026$0.00−$0.17$2.7M$2.5M−9.7%−1.7%
Aug 27, 2026$0.00$0.00$2.7M$2.7M0.0%+2.6%
Feb 25, 2026−$0.01−$0.20−2,586.2%$2.9M$3.0M+3.1%−1.1%
Aug 28, 2025−$0.01−$0.31−2,219.5%$2.0M$2.2M+7.9%+0.6%

The latest year is open to everyone — the 33 quarters behind it read with an account.

Sign in
Mar 31, 2025
Feb 28, 2025
Sep 30, 2024
Aug 29, 2024
Apr 29, 2024
Mar 31, 2024
Aug 30, 2023
Dec 30, 2022
Aug 31, 2022
Aug 30, 2022
Dec 30, 2021
Sep 7, 2021
Dec 30, 2020
Aug 30, 2020
Jun 30, 2020
Dec 30, 2019
Aug 30, 2019
Dec 30, 2018
Jun 30, 2018
Dec 30, 2017
Jun 30, 2017
Dec 30, 2016
Jun 30, 2016
Dec 30, 2015
Jun 30, 2015
Dec 30, 2014
Jun 30, 2014
Dec 30, 2013
Jun 30, 2013
Dec 30, 2012
Jun 30, 2006
Dec 30, 2005
Jun 30, 2003